Cargando…
Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre
SIMPLE SUMMARY: Surgery or conventional radical radiotherapy are established curative treatment options for patients with localised, stage I non-small-cell lung cancer (NSCLC). Another option, stereotactic ablative body radiotherapy (SABR), has emerged over the last decade. We sought to understand t...
Autores principales: | Stares, Mark, Lewis, Georgina, Vallet, Maheva, Killean, Angus, Tramonti, Giovanni, Patrizio, Ailsa, Mackean, Melanie, Harrow, Stephen, Barrie, Colin, MacLennan, Kirsty, Campbell, Sorcha, Evans, Tamasin, Tufail, Aisha, Hall, Peter, Phillips, Iain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000454/ https://www.ncbi.nlm.nih.gov/pubmed/36900224 http://dx.doi.org/10.3390/cancers15051431 |
Ejemplares similares
-
Hypoalbuminaemia as a Prognostic Biomarker of First-Line Treatment Resistance in Metastatic Non-small Cell Lung Cancer
por: Stares, Mark, et al.
Publicado: (2021) -
Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer
por: Stares, M., et al.
Publicado: (2022) -
Types of Bullet Wounds Observed in No. 3 Scottish General Hospital, Stobhill
por: MacLennan, Alex.
Publicado: (1915) -
The thistle study: a stepped-wedge clustered trial of an intrapartum emergencies training package in Scottish maternity units
por: Lenguerrand, Erik, et al.
Publicado: (2013) -
Characterisation and outcomes of patients referred to a regional cancer of unknown primary team: a 10-year analysis
por: Stares, Mark, et al.
Publicado: (2021)